RE:RE:RE:RE:diabetes patent awarded to LMNL Newcamo, I know youve been here a long time with other boardnames like Pepito. Exact same words used over and over again. Same spelling mistakes. So, you are 100% aware of 4050 metabolic syndrome open label Phase 2 trial in 2014? Are LMNL moving forward with this Phase 2 closed loop study or was there more interest in IPF Phase 2 after the MAD Phase 1 completion? I have not heard about diabetes going forward for a long,
long time. But, here you are punping it....
Newcamo wrote:
In fact diabetes drug market is projected to reach 78 billion$ u.s. by the end of 2026!
https://www.fortunebusinessinsights.com/industry-reports/diabetes-drugs-market-100570
Newcamo wrote:
This has huge partnership written all over it... diabetes market in 2018 was worth 50Billion u.s,...
realstocky wrote:
stock has been doing great for more than a week. Probably something big in the works, this diabetes breakthrough will be of huge interest with majors! Good luck bud.
Newcamo wrote:
Keep it on the downlo. PATENT $LMNL Liminal Biosciences granted European Patent No. EP3203998 by the European Patent Office, titled: SUBSTITUTED AROMATIC COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF DIABETES.
https://register.epo.org/application?number=EP15849445